• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, Feb. 26

Ethypharm India has entered into an out-licensing and supply agreement with Shantha Biotechnics for Ondansetron Flashtab, a medicine taken to prevent vomiting associated with chemotherapy treatment for cancer. Ethypharm is a subsidiary of French drug-delivery company Ethypharm SA. The products will be supplied from Ethypharm's manufacturing facility near Mumbai as packaged and finished dosage forms that will be marketed and distributed by Shantha Biotechnics. Ondansetron Flashtab is a useful form for patients who have difficulty with swallowing, and so provides an alternative to the conventional Ondansetron tablet, a note from the company said.

More Stories on : Alliances & Joint Ventures | Channels and Franchises | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
ONGC produces crude from marginal field

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line